Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
John Paul Clancy, MD CFF-TDN site Cystic Fibrosis Fdn Therapeutics, Inc AMIN09Y0/CLANCY14Y0 01/01/2013 - 12/31/2017 $112,468
Jason C Woods, PhD Severe Asthma Research Program National Institutes of Health (Washington University) U10 HL109257 02/01/2013 - 05/31/2017 $8,547
Michael Seid, PhD FL3X: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes National Institutes of Health (University of North Carolina) UC4 DK101132 09/15/2013 - 06/30/2018 $600,736
Anjaparavanda Naren, PhD Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea National Institutes of Health R01 DK080834 09/18/2013 - 03/31/2018 $333,313
Anjaparavanda Naren, PhD Characterization of an Inhibitory Protein Complex for Cystic Fibrosis Therapy National Institutes of Health (Univ of Tennessee Health Science Center) R01 HL123535 08/15/2014 - 06/30/2019 $17,539
Gary McPhail, MD Cystic Fibrosis Center Program Accreditation And Funding Cystic Fibrosis Foundation CC160-130 07/01/2013 - 06/30/2018 $150,270
Michael Seid, PhD Measures of Hypoglycemia and Glycemic Variability Using Continuous Glucose Monitoring in the FL3X Intervention for Youth With Type 1 Diabetes The Leona M & Harry B Helmsley Charitabl (University of North Carolina) 2014PG-T1D030 01/01/2014 - 12/31/2017 $8,100
John Paul Clancy, MD Pilot Development of Translational Primary Human Airway Model Systems to Advance CF Care Cystic Fibrosis Foundation CLANCY14XX0 07/01/2014 - 06/30/2018 $95,794
Anjaparavanda Naren, PhD CF-Patient Specific Enteroids from Small Intestine and Colon Cystic Fibrosis Fdn Therapeutics, Inc NAREN14XX0 07/01/2014 - 06/30/2018 $226,708
Jason C Woods, PhD Molecular Pathogenesis and Treatment of Pulmonary Alveolar Microlithiasis National Institutes of Health (University of Cincinnati) R01 HL127455 04/01/2015 - 03/31/2020 $36,075
John Paul Clancy, MD PROSPECT Cystic Fibrosis Fdn Therapeutics, Inc CLANCY14K1 07/01/2014 - 06/30/2019 $37,047
Anjaparavanda Naren, PhD LPA2 Receptor-containing Complexes in Regulating Secretory Diarrhea National Institutes of Health R01 DK093045 07/01/2015 - 06/30/2020 $351,000
Sara M Zak, MD First/Second Year Clinical Fellowship Grant Application Cystic Fibrosis Foundation ZAK15B0 07/01/2015 - 06/30/2017 $66,250
Raouf Samy Amin, MD Impact of Treatment of Mild Sleep-Disordered Breathing on Children’s Health-CCC National Institutes of Health (Children's Hospital of Philadelphia) U01 HL125295 09/04/2015 - 10/31/2016 $239,150
John Paul Clancy, MD TDC ARC Award Cystic Fibrosis Fdn Therapeutics, Inc CLANCY14Y4 12/01/2014 - 11/30/2018 $32,694
Zackary Cleveland, PhD Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury National Institutes of Health R00 HL111217 08/15/2015 - 07/31/2018 $242,816
William Hardie, MD
John Paul Clancy, MD		 Cincinnati Children's Summer Medical Student Respiratory Research Fellowship National Institutes of Health T35 HL113229 05/01/2016 - 04/30/2021 $68,526
John Paul Clancy, MD Personalizing Cystic Fibrosis Research Translation Cystic Fibrosis Foundation CLANCY15R0 07/01/2015 - 06/30/2019 $470,000
Gary McPhail, MD A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hosp & Reg Med Ct-Seattle) PROSPECT-OB-14 02/23/2015 - 02/22/2018 $83,492
John Paul Clancy, MD SHIP (Saline Hypertonic in Preschoolers) Study - Planning Grant Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hosp & Reg Med Ct-Seattle) SHIP14K0 11/01/2014 - 10/31/2018 $34,625
Daniel Grossoehme, D.Min. Training Research-Literate Chaplains as Ambassadors for Spirituality and Health: Phase I John Templeton Foundation (Rush Medical University Center) 51996 07/01/2015 - 06/30/2019 $8,826
Jason C Woods, PhD
John Paul Clancy, MD		 UTE MRI to Monitor CF Lung Disease and Response to CFTR Modulation in Young Children National Institutes of Health R01 HL131012 05/01/2016 - 03/31/2021 $745,633
Anjaparavanda Naren, PhD Human Small Intestinal Model from CF-Patients using Pluripotent Stem Cells Cystic Fibrosis Foundation NAREN16I0 04/01/2016 - 03/31/2018 $54,000
John J Brewington, MD Sensitivity of Corrected F508del CFTR to Chronic beta-agonist Therapy Cystic Fibrosis Foundation BREWIN16A0 07/01/2016 - 06/30/2019 $130,000
Zackary Cleveland, PhD Regional Biomarkers of Peripheral Lung Disease in Cystic Fibrosis Cystic Fibrosis Fdn Therapeutics, Inc CLEVEL16A0 04/01/2016 - 03/31/2019 $108,000
Anjaparavanda Naren, PhD Transporters and Hematopoietic Toxicity National Institutes of Health (St Jude's Children's Hospital) R01 CA194206 07/01/2016 - 06/30/2021 $23,595
Satish K Madala, PhD
Anil Goud Jegga, DVM		 Integrative Analysis of Multi-omics Data to Target Fibroblast Activation in IPF National Institutes of Health R21 HL133539 07/05/2016 - 06/30/2018 $63,929.50
Michael Seid, PhD A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System Cystic Fibrosis Fdn Therapeutics, Inc SEID15A0 01/01/2016 - 12/31/2018 $1,542,986
Satish K Madala, PhD WT1 Regulation of Pulmonary Fibrosis National Institutes of Health R01 HL134801 05/22/2017 - 04/30/2022 $409,242
John Paul Clancy, MD CFFT Biomarker Consortium Cystic Fibrosis Fdn Therapeutics, Inc CLANCY11CS0 01/01/2016 - 12/31/2017 $23,230
Assem Ziady, PhD Manipulating Vector Interactome to Enhance Gene Transfer in Cystic Fibrosis Cystic Fibrosis Foundation ZIADY1610 11/01/2016 - 10/31/2018 $54,000
Christopher Siracusa, MD CFF Success with Therapies Research Consortium Cystic Fibrosis Fdn Therapeutics, Inc SIRACU15PE0 08/01/2016 - 07/31/2018 $27,000
Geoffrey Walter Rulong, MD Custom 3-D Printed Non-invasive Ventilation Mask American Sleep Medicine Foundation 160-FP-17 02/14/2017 - 02/13/2018 $19,377
Raouf Samy Amin, MD Impact of Treatment of Mild Sleep-Disordered Breathing on Children’s Health-CCC National Institutes of Health (Children's Hospital of Philadelphia) U01 HL125295 07/01/2016 - 06/30/2020 $250,723
Christopher Siracusa, MD DESIGN CF: Developing e-Health Systems to Improve Growth and Nutrition in CF Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hospital Boston) CHB - Siracusa,Chris 01/01/2017 - 12/31/2017 $4,190
Theresa Guilbert, MD, MS Controlling and Preventing Asthma Progression and Severity in Kids (CASK) National Institutes of Health (Children's Hospital Boston) U01 AI126614 04/01/2017 - 06/30/2017 $50,000
Total Annual Grant Award Dollars $6,729,881.50

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Anjaparavanda Naren, PhD Ironwood Pharmaceuticals, Inc. $200,000
Gary McPhail, MD Vertex Pharmaceutical Incorporated $94,211
John Paul Clancy, MD Concert Pharmaceuticals, Inc $70,149
Raouf Samy Amin, MD Vertex Pharmaceutical Incorporated $15,000
Total Annual Industry Award Dollars $379,360